5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
Key Takeaways
- Catheter-directed thrombolysis embeds a multi-side-hole catheter inside the thrombus and infuses alteplase at roughly 0.5-1 mg/hour per catheter with no systemic bolus, so total lytic exposure is often 10-24 mg rather than the 100 mg systemic dose.
- Fibrinogen is the lytic safety lab: a value below about 150 mg/dL, or a fall of more than 50% from baseline, triggers rate reduction or discontinuation. Check fibrinogen, hemoglobin, platelets and aPTT every 4-6 hours and perform hourly neurologic checks.
- Retroperitoneal hemorrhage follows a femoral puncture above the inguinal ligament and presents with flank or back pain, unexplained hypotension and tachycardia and a falling hemoglobin, while the groin looks clean and the abdomen stays soft.
- A pulsatile groin mass with a systolic bruit and a to-and-fro Doppler signal is a pseudoaneurysm treated with ultrasound-guided compression or thrombin injection; a continuous machinery-like bruit without a pulsatile mass is an arteriovenous fistula.
- The femoral arteriotomy sits 1-2 cm cephalad to the skin nick, so compressing the skin puncture instead of the arteriotomy is the classic reason a hematoma keeps expanding despite apparently adequate pressure.
Catheter-Directed Thrombolysis: One Technique, Three Territories
The principle is dose localization. Instead of a systemic 100 mg alteplase dose distributed to every healed wound in the body, a multi-side-hole infusion catheter is embedded directly within the thrombus and delivers a low-rate infusion with no systemic bolus, concentrating drug where fibrin is and limiting systemic fibrinogenolysis. The CMC exam treats catheter-directed thrombolysis (CDT) as a monitoring assignment, not a procedure.
Indications by Territory
| Territory | Who gets CDT | Alternatives and adjuncts |
|---|---|---|
| Arterial — acute limb ischemia | Rutherford class I (viable) and class IIa (marginally threatened) limbs: sensory loss absent or limited to the toes, no motor deficit, and a limb that can tolerate the hours lysis requires | Class IIb (motor weakness, sensory loss beyond the toes) requires immediate revascularization by surgical embolectomy or percutaneous mechanical thrombectomy, because lysis is too slow. Class III (rigor, fixed mottling, absent arterial and venous Doppler) is irreversible: primary amputation, not lysis |
| Venous — iliofemoral DVT | Symptoms under 14 days, severe symptoms, low bleeding risk, good functional status and life expectancy; phlegmasia cerulea dolens is the strongest indication | Pharmacomechanical thrombectomy. Routine lysis of ordinary femoropopliteal DVT is not supported (ATTRACT) |
| Pulmonary — pulmonary embolism | Intermediate-high-risk PE (right ventricular strain on echo or CT plus a positive troponin) that is deteriorating, and high-risk (massive) PE when systemic lysis has failed or is contraindicated | Systemic alteplase 100 mg over 2 hours when catheter therapy is unavailable; large-bore mechanical/aspiration thrombectomy; surgical embolectomy; VA-ECMO as a bridge. Decisions increasingly route through a pulmonary embolism response team (PERT) |
Technique Variants
- Standard CDT — a plain multi-side-hole infusion catheter left in the clot for hours.
- Ultrasound-assisted CDT — high-frequency, low-power ultrasound loosens fibrin strands and exposes plasminogen receptors. Regimens are deliberately low dose and short, on the order of 1 mg/hour per catheter for the first several hours followed by 0.5 mg/hour, with total doses commonly around 10-24 mg.
- Pharmacomechanical thrombectomy — lytic plus aspiration or maceration in a single sitting, which shortens or eliminates the ICU infusion entirely.
- Mechanical or aspiration thrombectomy alone — no lytic at all. This is the option when bleeding risk forbids thrombolysis, such as recent surgery, recent stroke, or active bleeding.
Contraindications
Absolute: any prior intracranial hemorrhage; known cerebral vascular malformation or malignant intracranial neoplasm; ischemic stroke within 3 months; active internal bleeding; suspected aortic dissection; significant closed head or facial trauma within 3 months; intracranial or intraspinal surgery within 2 months.
Relative: uncontrolled hypertension above 180/110 mmHg; current anticoagulation with a supratherapeutic INR; major surgery within 3 weeks or internal bleeding within 2-4 weeks; traumatic or prolonged CPR; non-compressible vascular puncture; pregnancy; active peptic ulcer disease; advanced age; known bleeding diathesis.
Monitoring the Infusion
| Parameter | Frequency | Action threshold |
|---|---|---|
| Fibrinogen | every 4-6 hours | Below about 150 mg/dL, or a fall greater than 50% from baseline: reduce the rate or stop per protocol |
| Hemoglobin and hematocrit | every 4-6 hours | Any unexplained fall means occult bleeding until proven otherwise, especially retroperitoneal |
| Platelet count | every 6-12 hours | Below 100,000/microL: notify; consider HIT if heparin is running |
| aPTT or anti-Xa | per the concurrent heparin protocol | Subtherapeutic heparin risks pericatheter thrombosis; supratherapeutic compounds bleeding risk |
| Neurologic examination | hourly | Any new headache, confusion, focal deficit or seizure: stop the lytic immediately and obtain a stat non-contrast head CT |
| Puncture site and dressing | every 15-60 minutes | Oozing, expanding hematoma, or increasing site pain |
| Distal perfusion (arterial cases) | hourly with Doppler | Return of a signal indicates success; a worsening signal indicates failed lysis or distal embolization |
Stopping rules the nurse enacts: any suspected intracranial hemorrhage, major overt bleeding, new hemodynamic instability, or a critically low fibrinogen. Immediate management of major bleeding on a lytic is to stop the alteplase and the heparin, apply direct pressure, resuscitate with crystalloid and blood products, send fibrinogen and a type and crossmatch, and give cryoprecipitate to replace fibrinogen plus fresh frozen plasma, with tranexamic acid or aminocaproic acid as the antifibrinolytic and platelets if the patient is thrombocytopenic or on antiplatelet agents.
A patient is 8 hours into ultrasound-assisted catheter-directed thrombolysis for intermediate-high-risk pulmonary embolism. Baseline fibrinogen was 420 mg/dL and the current value is 130 mg/dL. There is no visible bleeding and the neurologic examination is unchanged. What is the most appropriate nursing action?
Post-Intervention Vascular Complications: Recognition and Immediate Action
| Complication | Recognition | Immediate nursing action |
|---|---|---|
| Retroperitoneal hematoma | Flank, back, or ipsilateral groin and thigh pain; unexplained hypotension with tachycardia; falling hemoglobin; diaphoresis and restlessness; sometimes neuropathic thigh pain from femoral nerve compression. The groin often looks normal and the abdomen stays soft, because blood tracks into a distensible space that does not resist. Risk factors: puncture above the inguinal ligament, large sheath, anticoagulation or lysis, obesity, female sex, small body habitus | Stop anticoagulants and any lytic, lay the patient flat, hold pressure at the site, establish large-bore IV access, give fluids and send a type and crossmatch, obtain a stat hemoglobin, notify the provider urgently, prepare for CT of the abdomen and pelvis and for transfusion, covered stent, or surgical repair |
| Femoral pseudoaneurysm | Pulsatile, tender groin mass; systolic bruit; to-and-fro Doppler signal in the neck of the sac on duplex; enlarging ecchymosis. Typically appears hours to days after the procedure | Bed rest, hold anticoagulation as ordered, mark the borders of the mass and time the mark, avoid vigorous palpation, notify for duplex. Treatment is ultrasound-guided compression or ultrasound-guided thrombin injection; surgery for large, expanding or infected lesions |
| Arteriovenous fistula | Continuous machinery-like bruit with a palpable thrill over the site, usually without a pulsatile mass; may be asymptomatic, or cause limb swelling or high-output symptoms if large | Document and notify; duplex confirms. Small fistulas often close spontaneously, larger ones need a covered stent or surgical repair |
| Acute access-site thrombosis or limb ischemia | The six Ps distal to the site — pain, pallor, pulselessness, paresthesia, paralysis, poikilothermia — or loss of a previously documented Doppler signal | Notify immediately, keep the limb flat and passively warm without applying external heat, apply no compression to that limb, anticipate heparin and urgent revascularization |
| Distal embolization | Sudden pain with a cool, mottled or blue toe while pulses remain palpable ("blue toe syndrome"), typically after atherectomy or wire manipulation | Doppler and document the level, protect and offload the extremity, notify. Managed with anticoagulation and sometimes aspiration or lysis |
| Contrast reaction | Immediate: urticaria, flushing, bronchospasm, angioedema, hypotension. Delayed: rash 1-7 days later | Stop the contrast, support airway/breathing/circulation, IM epinephrine for anaphylaxis, antihistamine and corticosteroid, IV fluids; document severity so future premedication is ordered |
| Contrast-associated acute kidney injury | Creatinine rise of 0.3 mg/dL or 50% within 48-72 hours, frequently non-oliguric | Isotonic hydration, hold nephrotoxins and metformin per policy, trend urine output and creatinine |
| Radial artery occlusion | Absent radial pulse or Doppler signal, often entirely asymptomatic because of ulnar collateral flow | Prevent it with patent hemostasis: use the lowest band pressure that stops bleeding while a plethysmographic or Doppler signal is preserved during ulnar compression, and deflate in scheduled increments |
| Forearm compartment syndrome | Escalating forearm pain out of proportion, especially pain on passive finger extension; a tense, swollen forearm; paresthesia. A radial pulse is often still present | Loosen or remove the constricting band and dressing, position the arm at heart level, notify the surgeon urgently and prepare for fasciotomy. Do not adopt a wait-and-see posture |
| Vascular closure device failure | Persistent oozing or an expanding hematoma; acute limb ischemia if the device occludes the lumen or embolizes; late site infection | Manual pressure over the arteriotomy, assess distal perfusion immediately, notify. A cool pulseless leg after device deployment is device-related occlusion until proven otherwise |
| Access-site infection | Erythema, warmth, induration, purulent drainage, fever days later | Culture, notify, do not manipulate or express the site |
The two discriminations the exam returns to again and again: retroperitoneal bleed versus vasovagal reaction (both give hypotension, but the bleed is tachycardic with a falling hemoglobin while the vagal event is bradycardic and resolves with fluids and atropine), and pseudoaneurysm versus arteriovenous fistula (systolic bruit with a pulsatile mass and to-and-fro flow versus a continuous bruit with a thrill and no mass).
Four hours after percutaneous coronary intervention through the right common femoral artery, a patient becomes restless and reports new right flank and back pain. Heart rate is 118/min and blood pressure is 84/52 mmHg. The abdomen is soft and non-tender, the groin dressing is dry with no visible hematoma, and hemoglobin has fallen from 12.6 to 9.1 g/dL. Which complication is most likely?
Sheath Removal, Hemostasis, and Activity Progression
Before You Pull
Verify the order and the coagulation parameters — commonly an activated clotting time under 150-180 seconds or an aPTT within a defined range before a femoral arterial sheath comes out — and confirm the heparin infusion has been off for the required interval. Have atropine, IV fluids and a patent IV ready. Take a baseline set of vital signs, mark bilateral distal pulses, and pre-medicate for pain, because pain is what drives the vagal response.
Technique
- Find the arteriotomy, not the skin nick. The sheath tracks at an angle, so the arterial entry sits 1-2 cm proximal (cephalad) to the skin puncture. Compressing the skin site instead of the arteriotomy is the classic reason a hematoma keeps expanding "despite pressure."
- Use three fingers: point pressure over the arteriotomy with enough distal coverage to control back-bleeding, while preserving a faint distal pulse or Doppler signal. Completely occluding the artery promotes access-site thrombosis and distal ischemia.
- Hold long enough: at least 10 minutes for a diagnostic arterial sheath and 20 minutes or more for an interventional or large-bore sheath, adding roughly 3-5 minutes per additional French size and longer if the patient is anticoagulated. Do not lift to peek — every check restarts the clot.
- Venous sheaths are pulled with lighter pressure and generally after arterial hemostasis is secured.
- After hemostasis, apply a pressure dressing, keep the leg straight with the head of bed at 30 degrees or less, and maintain bed rest — typically 2-4 hours after a closure device and 4-6 hours after manual compression of an interventional sheath, per unit protocol.
Vasovagal Reaction During Removal
Common in practice and near-universal on the exam: abrupt bradycardia, hypotension, nausea, yawning, pallor and diaphoresis as pain and manual pressure stimulate the vagus. The response is to maintain pressure on the site rather than letting go, lay the patient flat and elevate the legs, give a rapid crystalloid bolus, administer atropine 0.5-1 mg IV per order, and stop unnecessary stimulation. Adequate local anesthesia and analgesia prevent most episodes. The trap runs both ways: misreading pallor and diaphoresis as bleeding and abandoning site pressure, or dismissing a genuine hemorrhage as "just a vagal" — the discriminator is the heart rate and the hemoglobin.
Closure Devices and Radial Bands
Vascular closure devices — collagen plug, suture-mediated, or clip-based — shorten time to hemostasis and shorten bed rest, but they do not eliminate complications. They add device embolization, arterial stenosis or occlusion, and device-related infection to the usual list. Any patient with a cool, pulseless limb after device deployment has a device-related occlusion until proven otherwise.
Radial hemostasis bands are deflated in scheduled stepwise increments with a patency check at each step. The arm is kept at heart level, and no blood pressure cuff, venipuncture or IV goes in that arm. Teach the patient before discharge to report increasing forearm pain, tightness or swelling, because compartment syndrome can declare itself after they leave.
Activity Progression and Discharge Teaching
Progress deliberately: flat bed rest, then head-of-bed elevation, then dangling, then standing with assistance while the site is directly observed. The first ambulation is when a marginal clot fails, so it is a nursing event, not a task to delegate blindly. Teach the patient and family to apply firm direct pressure and call for help if the site bleeds; to avoid lifting more than about 10 pounds, strenuous activity, and stairs for the ordered interval; to shower rather than soak in a bath; and to report a new lump, pulsating mass, audible bruit, fever, drainage, numbness, coolness, or increasing pain in the limb.
Ninety minutes after a diagnostic catheterization via right radial access, a patient reports worsening right forearm pain. The forearm is tense and swollen, and pain increases sharply with passive extension of the fingers. The radial pulse is palpable and the hand is warm and pink. What is the best action?